The Castleman Criteria
A novel ruleset may give hope to iMCD patients who remain undiagnosed
William Aryitey |
When your symptoms belong to a rare illness, such as Castleman disease (a lymph node disorder), the diagnostic outlook is bleak. Idiopathic multicentric Castleman disease (iMCD) is a life-threatening subtype that affects multiple lymph nodes. With no established diagnostic protocol in place, sufferers may remain undiagnosed – or misdiagnosed with lymphoma or autoimmune disorders – for years. To offer a solution, a multinational team of investigators banded together to pioneer a set of identification criteria (1).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.